Literature DB >> 20135631

Risk of third and fourth tumors in patients with head and neck cancer.

Xavier León1, Vicenç Martínez, Montserrat López, Jacinto García, Miquel Quer.   

Abstract

BACKGROUND: The objective of our study was to analyze the incidence and location of second and subsequent tumors in patients after an index head and neck carcinoma.
METHODS: A retrospective study was made by reviewing clinical data prospectively collected from 3631 patients with head and neck cancer. Incidence, location, and histology of the second, third, and fourth tumors was evaluated.
RESULTS: During the follow-up, 839 second tumors, 147 third tumors, and 35 fourth tumors were diagnosed. The annual hazard ratio was 3.8% for second tumors, 5.1% for third tumors, and 7.8% for fourth tumors. The risk of second and subsequent neoplasms remained constant throughout the follow-up. There were significant differences in the risk of appearance between the second and third tumors (p < .0001), and between the third and fourth tumors (p = .005).
CONCLUSION: Patients with a second tumor after an index head and neck carcinoma have an increased risk for developing subsequent tumors.

Entities:  

Mesh:

Year:  2010        PMID: 20135631     DOI: 10.1002/hed.21348

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  4 in total

1.  [Recent advances in the treatment of laryngeal and hypopharyngeal carcinoma].

Authors:  H E Eckel
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

Review 2.  European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer.

Authors:  Ricard Simo; Patrick Bradley; Dominique Chevalier; Frederik Dikkers; Hans Eckel; Nayla Matar; Giorgio Peretti; Cesare Piazza; Mark Remacle; Miquel Quer
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-09       Impact factor: 2.503

3.  High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma.

Authors:  Marta Téllez-Gabriel; Irene Arroyo-Solera; Xavier León; Alberto Gallardo; Montserrat López; Maria V Céspedes; Isolda Casanova; Antonio López-Pousa; Miquel Quer; Maria A Mangues; Agustí Barnadas; Ramón Mangues; Miguel A Pavón
Journal:  Cancer Med       Date:  2013-10-31       Impact factor: 4.452

4.  Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary Guidelines.

Authors:  R Simo; J Homer; P Clarke; K Mackenzie; V Paleri; P Pracy; N Roland
Journal:  J Laryngol Otol       Date:  2016-05       Impact factor: 1.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.